What is NDC 71335-2521?

71335-2521 is the product NDC for Gabapentin, Gabapentin 300 mg/1 capsule, listed with the FDA by Bryant Ranch Prepack. It has 10 package NDCs, shown above in 10- and 11-digit form.

Bryant Ranch Prepack, NDC labeler code 71335. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Gabapentin?

561 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Gabapentin NDC 71335-2521 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)71335-2521Labeler and product segments. Claims need a package NDC.

Product NDC at billing width71335-2521Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
71335-2521-0	7133525210071335252100	20 CAPSULE in 1 BOTTLE (71335-2521-0)Marketed from Nov 4, 2024
71335-2521-1	7133525210171335252101	30 CAPSULE in 1 BOTTLE (71335-2521-1)Marketed from Nov 4, 2024
71335-2521-2	7133525210271335252102	90 CAPSULE in 1 BOTTLE (71335-2521-2)Marketed from Nov 4, 2024
71335-2521-3	7133525210371335252103	60 CAPSULE in 1 BOTTLE (71335-2521-3)Marketed from Nov 4, 2024
71335-2521-4	7133525210471335252104	120 CAPSULE in 1 BOTTLE (71335-2521-4)Marketed from Nov 4, 2024
71335-2521-5	7133525210571335252105	100 CAPSULE in 1 BOTTLE (71335-2521-5)Marketed from Nov 4, 2024
71335-2521-6	7133525210671335252106	28 CAPSULE in 1 BOTTLE (71335-2521-6)Marketed from Nov 4, 2024
71335-2521-7	7133525210771335252107	112 CAPSULE in 1 BOTTLE (71335-2521-7)Marketed from Nov 4, 2024
71335-2521-8	7133525210871335252108	84 CAPSULE in 1 BOTTLE (71335-2521-8)Marketed from Nov 4, 2024
71335-2521-9	7133525210971335252109	180 CAPSULE in 1 BOTTLE (71335-2521-9)Marketed from Nov 4, 2024

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Gabapentin
Generic name (nonproprietary): gabapentin
Active ingredients: Gabapentin — 300 mg/1
Dosage form: Capsule
Route: Oral
Labeler: Bryant Ranch PrepackNDC labeler code 71335
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 214956
Marketing start: May 10, 2021
Listing expires: Dec 31, 2026
Other FDA classes: Decreased Central Nervous System Disorganized Electrical Activity (Physiologic effect)
Identifiers: Product ID 71335-2521_9e261ec8-4838-464b-a004-0f9ce246c760SPL ID 9e261ec8-4838-464b-a004-0f9ce246c760SPL set ID 35ac6b11-7b1c-47a0-a4ba-c193a0bb5b01RxCUI 310431UNII 6CW7F3G59X

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N471335252100 followed by a unit qualifier and the quantity

Package 71335-2521-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Feb 20, 2025.

Indications (excerpt from the label)

Gabapentin capsules are indicated for: Management of postherpetic neuralgia in adults Adjunctive therapy in the treatment of partial onset seizures, with and without secondary generalization, in adults and pediatric patients 3 years and older with epilepsy Gabapentin is indicated for: Postherpetic neuralgia in adults (1) Adjunctive therapy in the treatment of partial onset seizures, with and without secondary generalization, in adults and pediatric patients 3 years and older with epilepsy (1)

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 71335-2521

What is NDC 71335-2521?: 71335-2521 is the product NDC for Gabapentin, Gabapentin 300 mg/1 capsule, listed with the FDA by Bryant Ranch Prepack. It has 10 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Gabapentin.
What is the active ingredient?: Gabapentin.
Who is the labeler?: Bryant Ranch Prepack, NDC labeler code 71335. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Gabapentin?: 561 other product NDCs are listed under this name. See all Gabapentin NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Gabapentin NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Gabapentin	Gabapentin 800 mg/1	TabletOral	St. Mary's Medical Park Pharmacy	60760-943	60760-0943-3060760-0943-90
gabapentin	Gabapentin 300 mg/1	CapsuleOral	REMEDYREPACK INC.	70518-4763	70518-4763-00
Gabapentin	Gabapentin 100 mg/1	CapsuleOral	Cardinal Health 107, LLC	55154-0581	55154-0581-00
Gabapentin	Gabapentin 100 mg/1	CapsuleOral	Advanced Rx of Tennessee, LLC	80425-0595	80425-0595-0180425-0595-0280425-0595-03+1 more
Gabapentin	Gabapentin 300 mg/1	CapsuleOral	REMEDYREPACK INC.	70518-4746	70518-4746-0070518-4746-0170518-4746-02+1 more
Gabapentin	Gabapentin 100 mg/1	CapsuleOral	REMEDYREPACK INC.	70518-4742	70518-4742-0070518-4742-02
Gabapentin	Gabapentin 400 mg/1	CapsuleOral	REMEDYREPACK INC.	70518-4740	70518-4740-00
Gabapentin	Gabapentin 300 mg/1	CapsuleOral	Cardinal Health 107, LLC	55154-0580	55154-0580-00
Gabapentin	Gabapentin 600 mg/1	Tablet, CoatedOral	Coupler LLC	67046-1233	67046-1233-03
Gabapentin	Gabapentin 200 mg/1	CapsuleOral	Trifluent Pharma, LLC	73352-231	73352-0231-01

All 562 Gabapentin NDCs

Other NDCs under ANDA 214956

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 214956
Product	Strength	Form · route	Labeler	Product NDC
Gabapentin	Gabapentin 100 mg/1	CapsuleOral	NuCare Pharmaceuticals,Inc.	68071-3759
Gabapentin	Gabapentin 100 mg/1	CapsuleOral	Preferred Pharmaceuticals Inc.	68788-4107
Gabapentin	Gabapentin 100 mg/1	CapsuleOral	Advanced Rx of Tennessee, LLC	80425-0595
Gabapentin	Gabapentin 300 mg/1	CapsuleOral	Camber Pharmaceuticals, Inc.	31722-149
Gabapentin	Gabapentin 100 mg/1	CapsuleOral	Camber Pharmaceuticals, Inc.	31722-148
Gabapentin	Gabapentin 400 mg/1	CapsuleOral	Camber Pharmaceuticals, Inc.	31722-150
Gabapentin	Gabapentin 100 mg/1	CapsuleOral	Northwind Health Company, LLC	82868-074
Gabapentin	Gabapentin 100 mg/1	CapsuleOral	A-S Medication Solutions	50090-7388
Gabapentin	Gabapentin 300 mg/1	CapsuleOral	Asclemed USA, Inc.	76420-869
Gabapentin	Gabapentin 100 mg/1	CapsuleOral	A-S Medication Solutions	50090-7389
Gabapentin	Gabapentin 100 mg/1	CapsuleOral	Asclemed USA, Inc.	76420-868
Gabapentin	Gabapentin 400 mg/1	CapsuleOral	Asclemed USA, Inc.	76420-870
Gabapentin	Gabapentin 100 mg/1	CapsuleOral	St. Mary's Medical Park Pharmacy	60760-669
Gabapentin	Gabapentin 300 mg/1	CapsuleOral	A-S Medication Solutions	50090-7420
Gabapentin	Gabapentin 300 mg/1	CapsuleOral	A-S Medication Solutions	50090-7421
Gabapentin	Gabapentin 100 mg/1	CapsuleOral	REMEDYREPACK INC.	70518-4493
Gabapentin	Gabapentin 100 mg/1	CapsuleOral	Aphena Pharma Solutions - Tennessee, LLC	71610-756
Gabapentin	Gabapentin 300 mg/1	CapsuleOral	Aphena Pharma Solutions - Tennessee, LLC	71610-753
Gabapentin	Gabapentin 400 mg/1	CapsuleOral	XLCare Pharmaceuticals, Inc.	72865-254
Gabapentin	Gabapentin 400 mg/1	CapsuleOral	Aphena Pharma Solutions - Tennessee, LLC	71610-757

Showing 20 of 24.